3 August 2022
Latham & Watkins Advises Arcutis Biotherapeutics in Public Offering
Advising firms
Deal team
11 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Brian Cuneo Lead | Latham & Watkins LLP | Partner | capital markets | Bay Area |
| Ross McAloon | Latham & Watkins LLP | Partner | capital markets | Orange County |
| Jacob Walsh | Latham & Watkins LLP | Associate | capital markets | Orange County |
| Caitlin Nguyen | Latham & Watkins LLP | Associate | capital markets | Orange County |
| Grace Lee | Latham & Watkins LLP | Partner | Not stated | Bay Area |
| Gregory Conyers | Latham & Watkins LLP | Associate | Not stated | Bay Area |
| Elizabeth Richards | Latham & Watkins LLP | Partner | regulatory | Washington, D.C. |
| Heather Deixler | Latham & Watkins LLP | Partner | regulatory | Bay Area |
| Betty Pang | Latham & Watkins LLP | Counsel | regulatory | Bay Area |
| Chad Jennings | Latham & Watkins LLP | Associate | regulatory | Washington, D.C. |
| Margaret Rote | Latham & Watkins LLP | Associate | regulatory | Washington, D.C. |
Stated terms
- Stated value
- USD 150m (US$150 million)
- What the figure measures
- Issue size
- Client
- Arcutis Biotherapeutics, Inc.Issuer
- Counterparties
- Not stated